Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing CRY1 via PI3K/AKT pathway
Yasushi Iida(Jikei University School of Medicine), Aikou Okamoto(Jikei University School of Medicine)
Cited by 13
Related Papers
Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma
|International Journal of Oncology|2012|68
Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway
|Gynecologic Oncology|2022|15